Ultrafast Analysis of Z-Drugs in Urine Using the Agilent RapidFire High-Throughput Mass Spectrometry System

Importance of the topic

Rapid and reliable detection of non-benzodiazepine hypnotics (Z-drugs) in biological fluids is essential in forensic toxicology, clinical toxicology, and workplace testing. Traditional chromatographic methods can be time-consuming and limit laboratory throughput. Implementing ultrafast sample processing and analysis workflows addresses growing demands for high-capacity screening and confirmation of zopiclone, zolpidem, and zaleplon in urine samples.

Study objectives and overview

This application study aimed to develop and validate a high-throughput RapidFire/MS/MS method for simultaneous quantitation of three common Z-drugs in urine. Key goals included:

• Reducing sample cycle time compared to conventional LC/MS/MS protocols
• Maintaining analytical performance—linearity, accuracy, precision, and minimal carryover
• Establishing a simple dilute-and-shoot sample preparation workflow

Methodology and instrumentation

Sample preparation involved 1:50 dilution of urine in water containing deuterated internal standards (zolpidem-d6, zopiclone-d4). After mixing and centrifugation, 10 µL injections were processed on an Agilent RapidFire 360 coupled to a 6460 Triple Quadrupole MS. A reversed-phase C4 SPE cartridge facilitated analyte capture and elution. Mobile phases included ammonium formate buffer, low-percentage acetonitrile aqueous washes, and 80 % methanol/20 % ethyl acetate organic washes. Target compounds and isotopic standards were monitored via MRM transitions under optimized collision energies. Data were acquired and processed using Agilent MassHunter software with 1/x-weighted linear calibration across 5–500 ng/mL.

Main results and discussion

• Linearity: All three Z-drugs exhibited R² values > 0.995 over 5–500 ng/mL.
• Accuracy and precision: Intraday and interday accuracy remained within ±10 %, and CVs were below 10 % at low, mid, and high QC levels.
• Throughput: Sample-to-sample cycle time was 15 s, enabling analysis of > 240 samples per hour—over 10× faster than typical LC/MS/MS workflows.
• Carryover and matrix effects: Blank injections following the highest calibrator showed no significant carryover. Matrix effects were under 10 %, indicating minimal ion suppression.

Applications and practical benefits

This ultrafast workflow supports both screening and confirmatory testing in forensic and clinical laboratories. Advantages include:

• Substantially increased throughput without sacrificing data quality
• Streamlined dilute-and-shoot preparation, reducing labor and consumable costs
• Rapid turnaround for time-sensitive cases such as impaired driving and workplace incidents

Future trends and opportunities

Implementation of high-throughput MS platforms is expected to expand to broader panels of drugs and metabolites. Integration with automated liquid-handling systems and advanced data-processing algorithms will further improve laboratory efficiency. Portable or benchtop ultrafast MS systems may enable near-real-time screening in clinical settings or roadside testing.

Conclusion

The described RapidFire/MS/MS method delivers rapid, accurate, and precise quantitation of zopiclone, zolpidem, and zaleplon in urine. By achieving cycle times of 15 s and maintaining robust analytical performance, this platform meets the increasing demand for high-throughput forensic toxicology workflows while offering comparable results to conventional LC/MS/MS approaches.

Reference

1. Rust KY, Maurer HH. Detection and validated quantification of 21 benzodiazepines and 3 ‘Z-drugs’ in human hair by LC-MS/MS. Forensic Science International. 2012;215:64–72.
2. Tonon MA, Bonato PS. Methods for the analysis of nonbenzodiazepine hypnotic drugs in biological matrices. Bioanalysis. 2012;4(3):291–304.